A retrospective study for improving survival for early relapse in patients with relapsed Hodgkin Lymphoma after Autologous Stem Cell Transplant
Latest Information Update: 13 Jan 2021
At a glance
- Drugs Brentuximab vedotin (Primary) ; Nivolumab (Primary) ; Pembrolizumab (Primary)
- Indications Hodgkin's disease
- Focus Therapeutic Use
- 13 Jan 2021 New trial record
- 08 Dec 2020 Results presented at the 62nd Annual Meeting and Exposition of the American Society of Hematology